Cargando…

Eltrombopag in long‐term management of pediatric thrombocytopenia

Eltrombopag is a thrombopoietin receptor agonist that may be effective in a broad range of thrombocytopenias of distinct etiology. We have observed rapid, robust, and sustained responses to eltrombopag in two young patients with refractory thrombocytopenia, one with primary immune thrombocytopenia a...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Sanjay J., Etzl, Michael M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333124/
https://www.ncbi.nlm.nih.gov/pubmed/30656041
http://dx.doi.org/10.1002/ccr3.1916
Descripción
Sumario:Eltrombopag is a thrombopoietin receptor agonist that may be effective in a broad range of thrombocytopenias of distinct etiology. We have observed rapid, robust, and sustained responses to eltrombopag in two young patients with refractory thrombocytopenia, one with primary immune thrombocytopenia and the other with Evans syndrome.